Items Tagged ‘Brain Cancer’

July 6, 2018

Engineering the Common Cold Virus Appears to be Promising Treatment Approach for Some Brain Tumors

By

A “smart bomb” oncolytic adenovirus appears to induce dramatic responses with long-term survival in recurrent high-grade gliomas, according to the early results of a study published in The Journal of Clinical Oncology. Glioblastoma is the most common and aggressive form of primary brain cancer in adults. With standard therapy — surgery followed by chemoradiation and […]

View full entry

Tags: Brain Cancer, News


May 30, 2018

Interim Survival Data from Phase 3 Trial of DCVax®-L for Glioblastoma Reported

By

Northwest Biotherapeutics, developer of DCVax® personalized immune therapies for solid tumor cancers, announced today the publication of interim blinded survival data from its Phase 3 clinical trial of DCVax®-L for newly diagnosed Glioblastoma brain cancer.  The data were collected by the independent contract research organization managing the trial, tabulated by an independent statistical firm and published with […]

View full entry

Tags: Brain Cancer, DCVax, Glioblastoma treatment, immunotherapy, News


May 29, 2018

Interim Results from Clinical Trial of Immunotherapy for Glioblastoma Show Significant Clinical Benefit

By

The research team behind an emerging immunotherapy for cancer will present interim findings from an ongoing clinical study in patients with brain cancer at a major research meeting next month. Collaborators from organizations including Roswell Park Comprehensive Cancer Center, the Cleveland Clinic and MimiVax LLC will share data from their phase II study of SurVaxM […]

View full entry

Tags: Brain Cancer, gliblastoma, immunotherapy, News, rosell park


March 31, 2009

Temodar® plus Radiation Improves Survival for Brain Cancer

By

Radiation therapy plus chemotherapy with Temodar® (temozolomide) improves survival in patients with glioblastoma; almost 10% of patients treated with the combination therapy were alive after five years, compared with 2% of patients treated with radiation alone. The results of this study were published in the Lancet Oncology. Glioblastoma multiforme (GBM) is one of the most common […]

View full entry

Tags: Brain Cancer